| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0022-510X(88)90206-7 |
| P698 | PubMed publication ID | 3225630 |
| P2093 | author name string | Blue JT | |
| Cooper BJ | |||
| de Lahunta A | |||
| Valentine BA | |||
| O'Quinn R | |||
| P2860 | cites work | Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles. | Q52255659 |
| P433 | issue | 1-3 | |
| P921 | main subject | Duchenne muscular dystrophy | Q1648484 |
| P304 | page(s) | 69-81 | |
| P577 | publication date | 1988-12-01 | |
| P1433 | published in | Journal of the Neurological Sciences | Q6296168 |
| P1476 | title | Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies. | |
| P478 | volume | 88 |
| Q36383108 | A Nonsense Variant in COL6A1 in Landseer Dogs with Muscular Dystrophy |
| Q54976963 | A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9. |
| Q36509738 | A possible new inherited myopathy in a young Labrador retriever |
| Q24535606 | Abiotrophy in domestic animals: a review |
| Q36422465 | Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy. |
| Q42859445 | Adaptive Immune Response Impairs the Efficacy of Autologous Transplantation of Engineered Stem Cells in Dystrophic Dogs |
| Q35819142 | Age-matched comparison reveals early electrocardiography and echocardiography changes in dystrophin-deficient dogs |
| Q72150601 | Alpha-dystroglycan deficiency correlates with elevated serum creatine kinase and decreased muscle contraction tension in golden retriever muscular dystrophy |
| Q30497616 | An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breed |
| Q28084979 | Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy |
| Q37696517 | Becker muscular dystrophy-like myopathy regarded as so-called "fatty muscular dystrophy" in a pig: a case report and its diagnostic method. |
| Q34665595 | Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs |
| Q58086427 | CRISPR Correction of Duchenne Muscular Dystrophy |
| Q90699692 | Canine Models of Inherited Musculoskeletal and Neurodegenerative Diseases |
| Q44059178 | Canine X-linked muscular dystrophy: Selective involvement of muscles in neonatal dogs |
| Q95404262 | Canine and Feline Models of Human Genetic Diseases and Their Contributions to Advancing Clinical Therapies |
| Q37548291 | Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies |
| Q33265240 | Cardiac involvement in Beagle-based canine X-linked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies |
| Q61596236 | Characterization of an antibody panel for immunohistochemical analysis of canine muscle cells |
| Q35019969 | Clinical phenotype of X-linked myotubular myopathy in Labrador Retriever puppies |
| Q37148808 | Comparative Genomics of X-linked Muscular Dystrophies: The Golden Retriever Model |
| Q78212609 | Contraction force generated by tarsal joint flexion and extension in dogs with golden retriever muscular dystrophy |
| Q40765598 | Creatine kinase in the dog: a review |
| Q37277411 | Current Challenges and Future Directions in Recombinant AAV-Mediated Gene Therapy of Duchenne Muscular Dystrophy |
| Q58091143 | Cycles of myofiber degeneration and regeneration lead to remodeling of the neuromuscular junction in two mammalian models of Duchenne muscular dystrophy |
| Q35817154 | Development of Duchenne-type cardiomyopathy. Morphologic studies in a canine model. |
| Q43173129 | Development of the cardiorespiratory system in dogs from days 16 to 46 of pregnancy |
| Q27309883 | Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation |
| Q38631895 | Dual AAV gene therapy for Duchenne muscular dystrophy with a 7-kb mini-dystrophin gene in the canine model |
| Q89448668 | Duchenne muscular dystrophy animal models for high-throughput drug discovery and precision medicine |
| Q42175045 | Duchenne muscular dystrophy gene therapy in the canine model |
| Q35641673 | Duchenne muscular dystrophy gene therapy in the canine model. |
| Q35052506 | Duchenne muscular dystrophy gene therapy: Lost in translation? |
| Q42234569 | Duchenne muscular dystrophy presenting with failure to thrive |
| Q44688951 | Duchenne's cardiomyopathy in a canine model: electrocardiographic and echocardiographic studies |
| Q35591025 | Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies |
| Q47694568 | Dysphagia and esophageal dysfunction due to dystrophin deficient muscular dystrophy in a male Spanish water spaniel. |
| Q44409495 | Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. |
| Q26781901 | Dystrophin-deficient large animal models: translational research and exon skipping |
| Q38365284 | Dystrophin-related muscular dystrophies |
| Q43173954 | Early loss of ambulation is not a representative clinical feature in Duchenne muscular dystrophy dogs: remarks on the article of Barthélémy et al. |
| Q34489678 | Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy |
| Q80121307 | Electrodiagnostic evaluation in feline hypertrophic muscular dystrophy |
| Q37460257 | Evaluation of vascular delivery methodologies to enhance rAAV6-mediated gene transfer to canine striated musculature |
| Q52648781 | Expression profiling of disease progression in canine model of Duchenne muscular dystrophy. |
| Q35817354 | Feline muscular dystrophy with dystrophin deficiency |
| Q80796644 | Gender dimorphism influences extracellular matrix expression and regeneration of muscular tissue in mdx dystrophic mice |
| Q35027808 | Gender influences cardiac function in the mdx model of Duchenne cardiomyopathy. |
| Q34566454 | Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors |
| Q37396408 | Gene therapy in large animal models of muscular dystrophy |
| Q42634221 | Genetic suppression of phenotypes arising from mutations in dystrophin-related genes in Caenorhabditis elegans. |
| Q36109634 | Genome-wide association study to identify potential genetic modifiers in a canine model for Duchenne muscular dystrophy |
| Q36013604 | Hematopoietic cell transplantation directly into dystrophic muscle fails to reconstitute satellite cells and myofibers |
| Q37345809 | Increased collagen cross-linking is a signature of dystrophin-deficient muscle. |
| Q48272661 | Increases in heart rate and systolic blood pressure in anesthetized dogs affected with X-linked muscular dystrophy after cisatracurium administration: a retrospective study |
| Q33736192 | Influence of immune responses in gene/stem cell therapies for muscular dystrophies |
| Q37011450 | Initial pulmonary respiration causes massive diaphragm damage and hyper-CKemia in Duchenne muscular dystrophy dog. |
| Q27317882 | Intra-amniotic rAAV-mediated microdystrophin gene transfer improves canine X-linked muscular dystrophy and may induce immune tolerance |
| Q37184680 | Kinematics of gait in golden retriever muscular dystrophy. |
| Q80616129 | Long-term follow-up of laminin alpha2 (merosin)-deficient muscular dystrophy in a cat |
| Q35802092 | Long-term restoration of cardiac dystrophin expression in golden retriever muscular dystrophy following rAAV6-mediated exon skipping |
| Q35612576 | Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy |
| Q33871731 | Longitudinal ambulatory measurements of gait abnormality in dystrophin-deficient dogs |
| Q34497055 | Mammalian models of Duchenne Muscular Dystrophy: pathological characteristics and therapeutic applications |
| Q36674598 | Mapping contrast agent uptake and retention in MRI studies of myocardial perfusion: case control study of dogs with Duchenne muscular dystrophy |
| Q33680413 | Mechanisms of resistance to pathogenesis in muscular dystrophies |
| Q48144419 | Morphological Characterization of the Myenteric Plexus of the Ileum and Distal colon of Dogs Affected by Muscular Dystrophy |
| Q44690673 | Morphological and ultrastructural evaluation of the golden retriever muscular dystrophy trachea, lungs, and diaphragm muscle. |
| Q39342422 | Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy |
| Q30300239 | Multiscale models of skeletal muscle reveal the complex effects of muscular dystrophy on tissue mechanics and damage susceptibility |
| Q64068599 | Mutation-Based Therapeutic Strategies for Duchenne Muscular Dystrophy: From Genetic Diagnosis to Therapy |
| Q88540277 | Myoediting: Toward Prevention of Muscular Dystrophy by Therapeutic Genome Editing |
| Q40490992 | Non-Targeted Metabolomics Analysis of Golden Retriever Muscular Dystrophy-Affected Muscles Reveals Alterations in Arginine and Proline Metabolism, and Elevations in Glutamic and Oleic Acid In Vivo |
| Q47153959 | Osteopontin is linked with AKT, FoxO1, and myostatin in skeletal muscle cells. |
| Q37164566 | PTEN contributes to profound PI3K/Akt signaling pathway deregulation in dystrophin-deficient dog muscle |
| Q34152280 | Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials |
| Q34424160 | Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy |
| Q28547478 | Profiles of Steroid Hormones in Canine X-Linked Muscular Dystrophy via Stable Isotope Dilution LC-MS/MS |
| Q38391853 | Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells. |
| Q37548295 | Respiratory dysfunction in unsedated dogs with golden retriever muscular dystrophy |
| Q33841381 | Selected disorders of muscle and the neuromuscular junction |
| Q28658055 | Small and large animal models in cardiac contraction research: advantages and disadvantages |
| Q37271889 | Sparing of the dystrophin-deficient cranial sartorius muscle is associated with classical and novel hypertrophy pathways in GRMD dogs |
| Q52621969 | Splitting of Pi and other ³¹P NMR anomalies of skeletal muscle metabolites in canine muscular dystrophy. |
| Q35765110 | Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs |
| Q37807624 | Stem cells to treat muscular dystrophies – Where are we? |
| Q35475301 | Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs |
| Q36590389 | TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy |
| Q92874029 | The Dog Model in the Spotlight: Legacy of a Trustful Cooperation |
| Q73755155 | The cranial sartorius muscle undergoes true hypertrophy in dogs with golden retriever muscular dystrophy |
| Q49156079 | The electroretinographic phenotype of dogs with Golden Retriever muscular dystrophy |
| Q33709114 | The golden retriever model of Duchenne muscular dystrophy |
| Q91105830 | The panniculus carnosus muscle: A novel model of striated muscle regeneration that exhibits sex differences in the mdx mouse |
| Q37975319 | The paradox of muscle hypertrophy in muscular dystrophy. |
| Q37383091 | The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies |
| Q33713019 | Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle |
| Q41844106 | Vascular endothelial dysfunction in Duchenne muscular dystrophy is restored by bradykinin through upregulation of eNOS and nNOS. |
| Q37727544 | Whole genome sequencing reveals a 7 base-pair deletion in DMD exon 42 in a dog with muscular dystrophy. |
| Q39376754 | Why short stature is beneficial in Duchenne muscular dystrophy |
Search more.